The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine.
Through this agreement, Lupin will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and Rifapentine 300 mg standalone tablets, at an affordable price
Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community
Dr. Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
There is also a growing interest in whole generation sequencing (WGS)
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
Olympus Corp was the market leader for endoscopy devices, accounting for around 23% of the global market in 2021.
Subscribe To Our Newsletter & Stay Updated
